Crossmark

Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States

Crossref DOI link: https://doi.org/10.1186/s12876-019-0972-6

Published Online: 2019-04-16

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Golabi, Pegah

Paik, James

Reddy, Rashmi

Bugianesi, Elisabetta

Trimble, Gregory

Younossi, Zobair M. https://orcid.org/0000-0001-9313-577X
License Information

Text and Data Mining valid from 2019-04-16
More Information

Article History

Received: 7 February 2019

Accepted: 31 March 2019

First Online: 16 April 2019

Ethics approval and consent to participate

: This study has been approved by Internal Review Board of Inova Fairfax Hospital (Federal Assurance FWA00000573); the approval number is NHANES IRB: 12.1074.

: Not applicable.

: Dr. Younossi is a consultant to BMS, Gilead, AbbVie, Intercept, and GSK. All other authors have no conflict of interest to disclose. The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.